Furthermore, LMP1 and E7 enhanced cancer cell proliferation and sensitivity to anti-cancer drugs by modulating PERK activity and cellular reactive oxygen species (ROS) levels both in vitro and in vivo. This evidence concerns the gene EIF2AK3 and cancer.